Allakos Revenue and Competitors

Claim your profile

Location

$162.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Allakos's estimated annual revenue is currently $6.5M per year.(i)
  • Allakos received $100.0M in venture funding in December 2017.
  • Allakos's estimated revenue per employee is $39,455
  • Allakos's total funding is $162.4M.
  • Allakos's current valuation is $415M. (January 2022)

Employee Data

  • Allakos has 165 Employees.(i)
  • Allakos grew their employee count by -5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.7M619%$53MN/A
#2
$34.3M17717%$110MN/A
#3
$0.4M2735%$236.7MN/A
#4
$34.5M178-5%$160MN/A
#5
$3.7M2420%N/AN/A
#6
$147.3M3212%$192.5MN/A
#7
$17.5M113-3%$24.1MN/A
#8
$2.7M4379%N/AN/A
#9
$34.1M220100%N/AN/A
#10
$47.1M304-3%N/AN/A

Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.

keywords:Biotechnology,Cleantech,Healthcare,Marketing,Pharmaceuticals,Wind Power

$162.4M

Total Funding

165

Number of Employees

$6.5M

Revenue (est)

-5%

Employee Growth %

$415M

Valuation

N/A

Accelerator

Allakos News

2022-04-20 - ALLAKOS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

(b) On April 15, 2022 , Mark Asbury informed Allakos Inc. (the "Company") of his decision to retire from his position as Chief Legal Officer and...

2022-04-20 - Ambys Medicines Expands Leadership Team with Key ...

Before Allakos, John held financial planning and analytics positions at Jaguar Health, BioMarin Pharmaceuticals, and Avinger, Inc. Earlier in...

2022-04-13 - Analysts Anticipate Allakos Inc. (NASDAQ:ALLK) to Announce ...

Allakos logo Equities analysts forecast that Allakos Inc. (NASDAQ:ALLK – Get Rating) will announce earnings of ($1.71) per share for the...

2019-09-08 - SG Americas Securities LLC Acquires 1,040 Shares of Allakos Inc (NASDAQ:ALLK)

SG Americas Securities LLC increased its stake in shares of Allakos Inc (NASDAQ:ALLK) by 27.5% during the 2nd quarter, according to the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.9M16744%N/A
#2
$44.4M178-10%N/A
#3
N/A17947%N/A
#4
$57.7M181-2%N/A
#5
$44.2M20114%$352.7M

Allakos Funding

DateAmountRoundLead InvestorsReference
2014-10-01$10.0MUndisclosedMultipleArticle
2017-12-14$100.0MANew Enterprise AssociatesArticle